PrescriptionGiant is a FREE prescription savings program that can save you up to 75% on your prescriptions with or without insurance!

Daunorubicin and Cytarabine Lipid Complex Injection

Actual product appearance may differ slightly.

Click the CARD below to print or take a screenshot on your mobile phone or tablet. There is no need to download another app!

If you would like to personalize your card enter your full name in the member name field below the card at this link and click the Update button.


WARNING

Other products containing these drugs differ from daunorubicin and cytarabine lipid combination, thus they shouldn’t be used interchangeably.

Why is this medication prescribed?

Some forms of acute myeloid leukaemia (AML; a type of malignancy of the white blood cells) in adults and children one year of age and older are treated with daunorubicin and cytarabine lipid combination. The drug daunorubicin belongs to the anthracycline drug class. Cytarabine belongs to the group of drugs known as antimetabolites. The proliferation of cancer cells in your body is slowed or stopped by the daunorubicin and cytarabine lipid complex.

How should this medicine be used?

In a hospital, a doctor or nurse will mix a powder form of daunorubicin and cytarabine with fluids before administering it intravenously (into a vein). On particular days during your treatment term, it is typically injected during a 90-minute period once each day.

For a copy of the manufacturer’s information for the patient, ask your chemist or doctor.

Other uses for this medicine

Ask your doctor or chemist for more details if you believe this drug should be used for something else.

What special precautions should I follow?

Before receiving daunorubicin and cytarabine lipid complex,

  • If you have any allergies, including to daunorubicin, cytarabine, other drugs, or any of the chemicals in daunorubicin and cytarabine lipid complex, let your doctor and chemist know right away. Get a list of the components from your pharmacist.
  • Inform your doctor and chemist about any additional prescription and over-the-counter drugs, vitamins, dietary supplements, and herbal products you are now taking or intend to use. Incorporate any of the following: isoniazid (INH, Laniazid, in Rifamate, in Rifater), methotrexate (Otrexup, Rasuvo, Trexall), acetaminophen (Tylenol, others), cholesterol-lowering drugs (statins), iron products, nicotinic acid (nicotinic acid), or rifampin (Rifadin, Rimactane, in Rifamate, in Rifater). Tell your doctor if you use or have ever taken certain cancer chemotherapy drugs, such as mitoxantrone, trastuzumab, doxorubicin (Doxil), epirubicin (Ellence), and idarubicin (Idamycin) (Herceptin). Your physician might need to adjust the dosage of your drugs or keep a close eye on you for side effects. Daunorubicin and cytarabine lipid complex may also interact with several other drugs, so be sure to let your doctor know about all the drugs you are taking, even if they do not appear on this list.
  • If you have or have ever had heart disease, a heart attack, Wilson’s disease (a condition that causes copper to build up in the body), an infection, blood-clotting issues, or anaemia, let your doctor know. Also let them know if you have ever had radiation therapy to the chest area (decreased amount of red blood cells in the blood).
  • Although you should be aware that this drug has the potential to make males infertile, you shouldn’t automatically think that you won’t be able to conceive another person. Inform your doctor if you intend to father a child, are already pregnant, or think you could become pregnant. While you are getting daunorubicin and cytarabine lipid combination, neither you nor your spouse should get pregnant. Throughout your daunorubicin and cytarabine lipid combination treatment and for six months following your final dosage, you should take birth control to avoid getting pregnant yourself or with your partner. Discuss effective birth control options with your doctor. Call your doctor right away if you fall pregnant while taking daunorubicin and cytarabine lipid combination. The foetus could suffer from the daunorubicin and cytarabine lipid combination.
  • Describe to your doctor if you are nursing a baby. For at least two weeks following your final dose of daunorubicin and cytarabine lipid combination, you should stop breastfeeding.
  • Inform the surgeon or dentist that you are receiving daunorubicin and cytarabine lipid complex if you are having surgery, including dental surgery.

What special dietary instructions should I follow?

Keep eating normally unless your doctor instructs you otherwise.

What side effects can this medication cause?

Side effects from the daunorubicin and cytarabine lipid combination are possible. If any of these symptoms are severe or do not go away, let your doctor know right once:

  • Nausea
  • Vomiting
  • Mouth- and throat-related sores
  • Constipation
  • Diarrhoea
  • Constipation
  • Abdominal pain
  • Tiredness
  • Joint or muscle ache
  • Headache
  • Feeling unsteady or lightheaded
  • Strange dreams or difficulty getting or keeping asleep during the night
  • Vision issues

Certain adverse effects can be very harmful. Call your doctor right away if you encounter any of these symptoms, or seek emergency care:

  • Where the drug was injected, any pain, itching, redness, swelling, blisters, or sores will be present
  • Rash
  • Hives
  • Itching
  • Breathing difficulty
  • Breathing or swallowing challenges
  • Edoema of the lower legs, ankles, feet, or hands
  • Hammering, rapid, or erratic heartbeat
  • Chest ache
  • Infection symptoms such as a fever, chills, sore throat, cough, frequent or painful urination, or other symptoms
  • Extreme fatigue or weakened state
  • Uncommon bruising or bleeding
  • Nosebleed
  • Stool that is dark and tarry
  • Bench with a reddish tint
  • Tainted vomit
  • Vomited substance that resembles coffee grounds
  • Eyes or skin that have a yellow tint
  • Ring around the eye’s iris that is dark brown or yellow

Further negative effects from the daunorubicin and cytarabine lipid combination are possible. If you experience any strange issues while taking this medicine, contact your doctor right away.

You or your doctor can submit a report to the Food and Drug Administration’s (FDA) MedWatch Adverse Event Reporting programme online or by phone if you have a serious side event (1-800-332-1088).

In case of emergency/overdose

Call the poison control hotline at 1-800-222-1222 in the event of an overdose. Moreover, information can be found online at https://www.poisonhelp.org/help. Call 911 right once if the person has collapsed, experienced a seizure, is having difficulty breathing, or cannot be roused.

What other information should I know?

Keep all of your appointments with your physician and the lab. To determine how your body is responding to the daunorubicin and cytarabine lipid combination, your doctor will request specific lab tests.

You should keep a written record of every medication you take, including any over-the-counter (OTC) items, prescription drugs, and dietary supplements like vitamins and minerals. This list should be brought with you whenever you see a doctor or are admitted to the hospital. You should always have this information with you in case of emergencies.

Brand names

  • Vyxeos®
Copyright © 2023 PrescriptionGiant.com